This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a home-country-based intermediary? a. Direct exports b. Indirect exports ... (Read 193 times)

Tazate

  • Hero Member
  • *****
  • Posts: 532
Which of the following is a home-country-based intermediary?
 a. Direct exports
 b. Indirect exports
 c. Segregated exports
 d. Integrated exports

Question 2

Luke is interviewing for a job. As part of the process, he meets with potential co-workers at a cocktail reception. After just 30 minutes at the reception, he leaves. When questioned by his friends, Luke replies, I just knew right away after meeting some of the employees that this company isn't for me. This scenario illustrates:
 a. classical conditioning.
 b. thin slice theory.
 c. central route processing from the elaboration likelihood model.
 d. the assimilation effect.
 e. the priming effect.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

janeli

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

b

Answer to Question 2

b




Tazate

  • Member
  • Posts: 532
Reply 2 on: Jun 29, 2018
Wow, this really help


ecabral0

  • Member
  • Posts: 310
Reply 3 on: Yesterday
Excellent

 

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library